lantronix_8k-050808.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported)
May
8, 2008
LANTRONIX,
INC.
(Exact
name of registrant as specified in its charter)
|
DELAWARE
|
|
1-16027
|
|
33-0362767
|
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification
No.)
|
15353
Barranca Parkway
Irvine,
California 92618
(Address
of principal executive offices, including zip code)
(949) 453-3990
(Registrant's
telephone number, including area code)
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[
] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[
] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[
] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[
] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02
Results of Operations and Financial Condition.
On May 8,
2008, Lantronix, Inc. (the “Company”) issued a press release announcing
preliminary results for its third fiscal quarter ended March 31, 2008. The
full text of this press release is attached as Exhibit 99.1 to this Current
Report on Form 8-K and is incorporated by reference herein.
In
accordance with General Instruction B.2 of Form 8-K, the information in
this Current Report on Form 8-K, including Exhibit 99.1, is being
“furnished” and shall not be deemed “filed” for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or
otherwise subject to the liabilities of that Section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended (the “Securities Act”) or the Exchange Act, except if the Company
specifically states that the information is to be considered “filed” under
the Exchange Act or incorporates it by reference into a filing under the
Securities Act or the Exchange Act.
Item
9.01 Financial Statements and Exhibits.
(d)
|
Exhibit
Number
|
|
Description
|
|
99.1
|
|
Press
Release dated May 8, 2008.
|
|
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
Date:
May 8, 2008
|
LANTRONIX,
INC.
|
|
|
|
|
|
|
By:
|
/s/
Jerry D. Chase
|
|
|
|
|
Jerry
D. Chase
President
and Chief Executive Officer
|
EXHIBIT
INDEX
|
Exhibit
Number
|
|
Description
|
|
99.1
|
|
Press
Release dated May 8, 2008.
|
|
|
|